To investigate the serious complications after interventional therapy of cardiovascular disease
探讨心血管疾病介入治疗后严重并发症

摘要

目的 对临床心血管疾病介入治疗后严重并发症问题进行探讨。方法 选择我院2020年3月至2022年5月间实施介入治疗的心血管疾病患者400例，其中30例患者在接受介入治疗后出现了严重并发症，本次研究以及30例并发症患者作为研究对象，对所有患者治疗及并发症具体状况进行统计研究。结果 经数据统计梳理发现心脏择期组接受介入治疗后并发症发生率为9.32%，心脏急诊组进行介入治疗后出现严重并发症的整体概率为7.92%，作为血管组进行介入治疗后出现严重并发症的正廷占率为6.52%，心脏择期组介入治疗后严重并发症的发生率明显高于其他组，差异显著，P<0.05。心血管疾病介入治疗后严重并发症临床表现具体为严重心律失常、穿刺点血肿、造影剂量过敏休克等，三种临床症状的发生率分别为23.33%、16.67%、16.67%，与其他临床症状相比较，差异显著，P<0.05。结论 穿刺点血肿、心律失常、造影剂过敏休克是临床心血管疾病介入治疗后集中常见的并发症，在介入治疗中应该给予重点关注，采取有效对策来有效控制并发症发生率及死亡率。

Abstract

Objective To investigate the serious complications after interventional therapy of clinical cardiovascular disease.
Methods 400 patients with cardiovascular disease who received interventional therapy in our hospital from March 2020 to May 2022 were selected, among which 30 patients had serious complications after receiving interventional therapy. This study and 30 patients with complications were taken as research objects, and the specific status of treatment and complications of all patients were statistically studied.
Results The statistical analysis showed that the complication rate was 9.32% in the elective cardiac group, 7.92% in the emergency cardiac group, and 6.52% in the vascular group. The incidence of serious complications in the elective group was significantly higher than that in the other groups (P<0.05). The clinical manifestations of serious complications after interventional therapy of cardiovascular diseases were severe arrhythmia, hematoma at puncture point, anaphylactic shock at contrast dose, etc. The incidence of these three clinical symptoms were 23.33%, 16.67%, 16.67%, respectively, and compared with other clinical symptoms, the difference was significant (P<0.05).
Conclusion   Puncture point hematoma, arrhythmia and contrast anaphylactic shock are common complications after interventional therapy of clinical cardiovascular diseases. Attention should be paid to the interventional therapy and effective countermeasures should be taken to effectively control the incidence of complications and mortality.